Executive Profile

Daniel Tassé Chairman and Chief Executive Officer, Ikaria, Inc.

Age	Total Calculated Compensation	This person is connected to 2 Board Members in 2 different organizations across 1 different industries. See Board Relationships
52	--

Background

Mr. Daniel Tassé has been Chairman of the Board of Ikaria Holdings, Inc. since October 2009 and also its Chief Executive Officer since January 2008. Mr. Tassé served as President of Ikaria, Inc since January 2008. Mr. Tassé served as the General Manager of Baxter International's $2 billion Pharmaceuticals & Technologies business, a division created by integrating its Anesthesia, Critical Care and BioPharma Solutions Business units. Prior to his tenure at Baxter International, ... he held management positions at GlaxoSmithKline and Upjohn. He has been Director of Ikaria Holdings, Inc. since January 2008. He has been a Director and a Member of Health Section Governing Board at Biotechnology Industry Organization since July 2011. Mr. Tassé holds a B.Sc. in Biochemistry from the University of Montreal.

Corporate Headquarters 53 Frontage Road Hampton, New Jersey 08827-9001 United States Phone: 908-238-6600 Fax: 908-238-6633 Board Members Memberships Director Biotechnology Industry Organization 2008-Present Chairman and Chief Executive Officer Ikaria, Inc. Education BS Universite De Montreal, L' Other Affiliations Universite De Montreal, L' Biotechnology Industry Organization

Annual Compensation There is no Annual Compensation data available. Stocks Options There is no Stock Options data available. Total Compensation There is no Total Compensation data available.

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.